Endo Health Solutions Inc (ENDP)

ENDP (NASDAQ:Drugs)
$34.38
pos +1.07
+3.21%
Today's Range: 33.17 - 34.55 | ENDP Avg Daily Volume: 2,642,200
Last Update: 05/17/13 - 4:00 PM EDT
Volume: 2,239,472
YTD Performance: 26.99%
Open: $33.32
Previous Close: $33.31
52 Week Range: $25.01 - $38.32
Oustanding Shares: 112,240,884
Market Cap: 3,738,743,846
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 8
Moderate Buy 0 0 0 0
Hold 8 7 5 9
Moderate Sell 0 0 0 0
Strong Sell 4 3 3 2
Mean Rec. 2.68 2.44 2.38 2.37
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -6.05
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-6.05 0.00 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.11% 2.78% 55.51%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 1.07 0.27
Net Income -100.00 -3.58 0.00
EPS -100.00 -3.82 0.00
Earnings for ENDP:
EBITDA 0.96B
Revenue 3.03B
Average Earnings Estimates
Qtr (06/13) Qtr (09/13) FY (12/13) FY (12/14)
Average Estimate $1.17 $1.07 $4.31 $3.63
Number of Analysts 12 11 14 13
High Estimate $1.23 $1.21 $4.70 $4.29
Low Estimate $1.11 $0.96 $4.00 $2.81
Prior Year $1.27 $1.28 $5.02 $4.31
Growth Rate (Year over Year) -8.20% -16.05% -14.06% -15.79%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
BioWireFeed
BioWireFeed: Some Bear Sentiment Names, High Put/Call Volume: Endo $ENDP (27) Ironwood $IRWD (25) Synta $SNTA (10) Derma $DSCI (10) BioMarin $BMRN (6)
2 days ago from web
jkreiling3
jkreiling3: @jimcramer how do you feel about $ENDP recovery from Monday's drop?
2 days ago from Twitter for Android
Sumenn7063
Sumenn7063: RT @SeekingAlpha: Last Week's 13D/G Filings By Leading Fund Managers In Healthcare And Technology http://t.co/aqMwyuehuQ $CRM $CTRP $CTRX $CTXS $ENDP
3 days ago from Twitter for iPhone
Alexability
Alexability: Top sentiment for SP1500 stocks: $ENDP,$EGN,$BMR,$CPRT,$RRC (2013/05/16) #sentiment #stock #alexandria
3 days ago from Alexability
SwingTradeAlert
SwingTradeAlert: RT @wallstCS: Analysts: Bristol-Myers Shares Will Give Back Gains and 3 More Research Notes to Check Out http://t.co/xO7tNLh8eR $BMY $ENDP $CSCO $F
3 days ago from stefanJobes
wallstCS
wallstCS: Analysts: Bristol-Myers Shares Will Give Back Gains and 3 More Research Notes to Check Out http://t.co/xO7tNLh8eR $BMY $ENDP $CSCO $F
3 days ago from WSCSCustomApp
SeekingAlpha
SeekingAlpha: Last Week's 13D/G Filings By Leading Fund Managers In Healthcare And Technology http://t.co/aqMwyuehuQ $CRM $CTRP $CTRX $CTXS $ENDP
3 days ago from Seeking Alpha
RatingsNetwork
RatingsNetwork: Endo Pharmaceuticals $ENDP was upgraded by analysts at Buckingham Research to a "buy" rating. http://t.co/ZOsFhw309H
4 days ago from Analyst Ratings Network
karleggerss
karleggerss: Street #upgrades: $F $BEAM $STZ $ENDP $YOKU $SRI $SPWR $TAP $ROSE $BUSE $CNW $BZH $INXN
4 days ago from StockTwits Web
TheStockMD
TheStockMD: Watchlist $ANF $CF $ENDP $LNG $RWT $TSCO $URBN http://t.co/i9HAYKlAKT
4 days ago from chrome-share
Bearish
Endo price target and estimates reduced at UBS
May 13, 2013 | 8:16 AM EDT
ENDP estimates were reduced after the FDA denied Opana CP, said UBS. Price target goes to $39.
Bearish
Endo Health downgraded at Lazard
May 13, 2013 | 8:05 AM EDT
ENDP was downgraded from Neutral to Sell, Lazard Capital Markets said. $27 price target. FDA denied Opana CP. 
Bearish
Endo Pharmaceuticals downgraded at Piper
Feb 25, 2013 | 8:35 AM EST
ENDP was downgraded from Neutral to Underweight, Piper Jaffray said. $22 price target. Outlook for generic competition remains uncertai...
Bearish
Endo Health Solutions downgraded at Oppenheimer
Jan 31, 2013 | 8:23 AM EST
Shares of ENDP downgraded to Perform from Outperform, Oppenheimer said. Valuation call.
Bearish
Endo Health Solutions numbers lowered at UBS
Jan 04, 2013 | 8:19 AM EST
Shares of ENDP now seen reaching $40, UBS said. Estimates also lowered on 2013 guidance. Buy rating.
Bearish
Endo Health Solutions numbers lowered at Oppenheimer
Jan 04, 2013 | 8:00 AM EST
Shares of ENDP now seen reaching $32, Oppenheimer said. Estimates also lowered generic competition. Outperform rating.
Bearish
Endo Pharmaceuticals downgraded at Piper
Jan 04, 2013 | 7:48 AM EST
ENDP was downgraded from Overweight to Neutral, Piper Jaffray said. Opana ER is facing generic competition. $28 price target. 
Bearish
Endo Health downgraded at Needham
Dec 14, 2012 | 6:58 AM EST
ENDP was downgraded from Hold to Underperform, Needham said. Core franchises will likely continue to deteriorate.   
Bearish
Endo numbers cut at UBS
Oct 05, 2012 | 8:12 AM EDT
Shares of ENDP now seen reaching $45, UBS said. Estimates also lowered following investor day. Buy rating. 
Bullish
Endo Pharmaceuticals added to US 1 List at BofA/Merrill
Sep 10, 2012 | 7:53 AM EDT
ENDP was placed on the US 1 list, Bank of America/Merrill Lynch said. Opana ER market share should soon recover. Buy rating and $40 pri...

Our Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.